All stock lists
Unlock the score
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.57+0.04 (+1.13%)
Insider Score
/ 100
VRCA Insider Score
Verrica Pharmaceuticals Inc. has a live Insider Score.
Scored on 6 qualifying trades from 4 insiders in the last 90 days.
VRCA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 5.86 M | 5.02 M | 5.09 M | 14.34 M | 12.70 M | 3.44 M |
| Revenue Growth (YoY) | -53.85 % | 46.06 % | 1380.23 % | 905.39 % | 145.35 % | -10.12 % |
| Cost of Revenue | 878.00 K | 889.00 K | 1.40 M | 1.11 M | 494.00 K | 423.00 K |
| Gross Profit | 4.98 M | 4.13 M | 3.69 M | 13.23 M | 12.21 M | 3.02 M |
| SG&A Expense | 10.35 M | 9.99 M | 8.12 M | 9.40 M | 8.85 M | 8.85 M |
| R&D Expense | 6.03 M | 3.86 M | 2.52 M | 2.21 M | 1.85 M | 2.28 M |
| Operating Expenses | 18.08 M | 13.85 M | 10.64 M | 11.61 M | 10.70 M | 11.15 M |
| Operating Income | -13.10 M | -9.71 M | -6.95 M | 1.63 M | 1.51 M | -8.13 M |
| Pretax Income | -13.15 M | -9.68 M | -8.07 M | -274.00 K | 204.00 K | -9.74 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -13.15 M | -9.68 M | -8.07 M | -274.00 K | 204.00 K | -9.74 M |
| EPS (Basic) | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| EPS (Diluted) | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 | -1.03 |
| Shares Outstanding | 21.31 M | 21.31 M | 10.65 M | 9.49 M | 9.49 M | 9.48 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.